[HTML] springer.comFull View

[HTML][HTML] Shisa3 brakes resistance to EGFR-TKIs in lung adenocarcinoma by suppressing cancer stem cell properties

J Si, Y Ma, JW Bi, Y Xiong, C Lv, S Li, N Wu… - Journal of Experimental & …, 2019 - Springer
Background Although EGFR tyrosine kinase inhibitors (EGFR-TKIs) are beneficial to lung
adenocarcinoma patients with sensitive EGFR mutations, resistance to these inhibitors …
被引用次数：27 相关文章

Shisa3 brakes resistance to EGFR-TKIs in lung adenocarcinoma by suppressing cancer stem cell properties

J Si, Y Ma, JW Bi, Y Xiong, C Lv, S Li, N Wu… - Journal of Experimental …, 2019 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
Although EGFR tyrosine kinase inhibitors (EGFR-TKIs) are beneficial to lung …
[HTML] biomedcentral.com

[HTML][HTML] Shisa3 brakes resistance to EGFR-TKIs in lung adenocarcinoma by suppressing cancer stem cell properties

J Si, Y Ma, JW Bi, Y Xiong, C Lv, S Li… - … of Experimental & …, 2019 - jeccr.biomedcentral.com
Although EGFR tyrosine kinase inhibitors (EGFR-TKIs) are beneficial to lung
adenocarcinoma patients with sensitive EGFR mutations, resistance to these inhibitors …

Shisa3 brakes resistance to EGFR-TKIs in lung adenocarcinoma by suppressing cancer stem cell properties.

J Si, Y Ma, JW Bi, Y Xiong, C Lv, S Li, N Wu… - Journal of Experimental …, 2019 - go.gale.com
Background Although EGFR tyrosine kinase inhibitors (EGFR-TKIs) are beneficial to lung
adenocarcinoma patients with sensitive EGFR mutations, resistance to these inhibitors …

Shisa3 brakes resistance to EGFR-TKIs in lung adenocarcinoma by suppressing cancer stem cell properties

J Si, Y Ma, JW Bi, Y Xiong, C Lv… - … of experimental & …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Although EGFR tyrosine kinase inhibitors (EGFR-TKIs) are beneficial to lung
adenocarcinoma patients with sensitive EGFR mutations, resistance to these inhibitors …

Shisa3 brakes resistance to EGFR-TKIs in lung adenocarcinoma by suppressing cancer stem cell properties

J Si, Y Ma, JW Bi, Y Xiong, C Lv, S Li… - … of Experimental and …, 2019 - search.proquest.com
Background Although EGFR tyrosine kinase inhibitors (EGFR-TKIs) are beneficial to lung
adenocarcinoma patients with sensitive EGFR mutations, resistance to these inhibitors …
[HTML] nih.gov

[HTML][HTML] Shisa3 brakes resistance to EGFR-TKIs in lung adenocarcinoma by suppressing cancer stem cell properties

J Si, Y Ma, JW Bi, Y Xiong, C Lv, S Li… - … of Experimental & …, 2019 - ncbi.nlm.nih.gov
Background Although EGFR tyrosine kinase inhibitors (EGFR-TKIs) are beneficial to lung
adenocarcinoma patients with sensitive EGFR mutations, resistance to these inhibitors …

Shisa3 brakes resistance to EGFR-TKIs in lung adenocarcinoma by suppressing cancer stem cell properties.

J Si, Y Ma, JW Bi, Y Xiong, C Lv, S Li… - … of Experimental & …, 2019 - search.ebscohost.com
Background: Although EGFR tyrosine kinase inhibitors (EGFR-TKIs) are beneficial to lung
adenocarcinoma patients with sensitive EGFR mutations, resistance to these inhibitors …

Shisa3 brakes resistance to EGFR-TKIs in lung adenocarcinoma by suppressing cancer stem cell properties.

J Si, Y Ma, JW Bi, Y Xiong, C Lv, S Li… - … of Experimental & …, 2019 - europepmc.org
BACKGROUND: Although EGFR tyrosine kinase inhibitors (EGFR-TKIs) are beneficial to
lung adenocarcinoma patients with sensitive EGFR mutations, resistance to these inhibitors …

Shisa3 brakes resistance to EGFR-TKIs in lung adenocarcinoma by suppressing cancer stem cell properties.

J Si, Y Ma, JW Bi, Y Xiong, C Lv, S Li… - … of Experimental & …, 2019 - europepmc.org
BACKGROUND: Although EGFR tyrosine kinase inhibitors (EGFR-TKIs) are beneficial to
lung adenocarcinoma patients with sensitive EGFR mutations, resistance to these inhibitors …